Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lukka

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Gynecologic Oncology|June 28, 2001
Cutaneous metastasis of papillary serous uterine cancerL Elit, H Lukka, E Friedman
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|December 1, 1990
The use of CT for selectron patientsJ Palmer, R Pearcey, H Lukka
The British Journal of Radiology|November 1, 1994
High dose rate versus low dose rate brachytherapy for squamous cell carcinoma of the cervix: an economic analysisG Jones, H Lukka, B O'Brien
Human Pathology|October 1, 1992
Primitive neuroectodermal tumors of the uterus: a report of four casesD Daya, H Lukka, P B Clement
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 1994
Patient preference for high or low dose rate brachytherapy in carcinoma of the cervixJ Wright, G Jones, T Whelan, et al.
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC|October 10, 1998
Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site GroupM D Brundage, J M Crook, H Lukka
International Journal of Radiation Biology|June 19, 2004
Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatinC Caney, G Singh, H Lukka, et al.
Clinical and Vaccine Immunology : CVI|December 28, 2012
Serodiagnosis of human cutaneous anthrax in India using an indirect anti-lethal factor IgG enzyme-linked immunosorbent assayN Ghosh, I Tomar, H Lukka, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 21, 2001
Systematic overview of the evidence for brachytherapy in clinically localized prostate cancerJ Crook, H Lukka, L Klotz, et al.
Current Oncology (Toronto, Ont.)|June 20, 2007
Maximal androgen blockade for the treatment of metastatic prostate cancer--a systematic reviewH Lukka, T Waldron, L Klotz, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology|June 28, 2001
Cutaneous metastasis of papillary serous uterine cancerL Elit, H Lukka, E Friedman
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|December 1, 1990
The use of CT for selectron patientsJ Palmer, R Pearcey, H Lukka
The British Journal of Radiology|November 1, 1994
High dose rate versus low dose rate brachytherapy for squamous cell carcinoma of the cervix: an economic analysisG Jones, H Lukka, B O'Brien
Human Pathology|October 1, 1992
Primitive neuroectodermal tumors of the uterus: a report of four casesD Daya, H Lukka, P B Clement
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 1994
Patient preference for high or low dose rate brachytherapy in carcinoma of the cervixJ Wright, G Jones, T Whelan, et al.
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC|October 10, 1998
Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site GroupM D Brundage, J M Crook, H Lukka
International Journal of Radiation Biology|June 19, 2004
Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatinC Caney, G Singh, H Lukka, et al.
Clinical and Vaccine Immunology : CVI|December 28, 2012
Serodiagnosis of human cutaneous anthrax in India using an indirect anti-lethal factor IgG enzyme-linked immunosorbent assayN Ghosh, I Tomar, H Lukka, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 21, 2001
Systematic overview of the evidence for brachytherapy in clinically localized prostate cancerJ Crook, H Lukka, L Klotz, et al.
Current Oncology (Toronto, Ont.)|June 20, 2007
Maximal androgen blockade for the treatment of metastatic prostate cancer--a systematic reviewH Lukka, T Waldron, L Klotz, et al.
Pageof 3